<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04664881</url>
  </required_header>
  <id_info>
    <org_study_id>20-001646</org_study_id>
    <nct_id>NCT04664881</nct_id>
  </id_info>
  <brief_title>Home Telemonitoring In Patients After Myocardial Infarction</brief_title>
  <official_title>Home Telemonitoring In Patients After Myocardial Infarction, HELP ME Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being done to determine if taking an electrocardiogram (ECG) by a portable&#xD;
      device (SmartHeart) followed by a phone call will improve patient outcomes by early&#xD;
      recognition of abnormalities and decrease emergency room visits and hospital readmissions&#xD;
      compared to standard therapy alone.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Emergency Room Visits</measure>
    <time_frame>90 days after hospital discharge</time_frame>
    <description>Number of emergency room visits over a period of 90 days after an index hospitalization for an acute myocardial infarction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Re-hospitalizations</measure>
    <time_frame>90 days after hospital discharge</time_frame>
    <description>Number of re-hospitalizations over a period of 90 days after an index hospitalization for an acute myocardial infarction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>90 days after hospital discharge</time_frame>
    <description>Number of deaths over a period of 90 days after an index hospitalization for an acute myocardial infarction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major Adverse Cardiovascular Events</measure>
    <time_frame>90 days after hospital discharge</time_frame>
    <description>Number of major adverse cardiovascular events including cardiovascular death and hospitalization for myocardial infarction, unstable angina, repeat revascularization, heart failure, stroke, arrhythmias, and cardiac arrest over a period of 90 days after an index hospitalization for an acute myocardial infarction</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Heart Attack</condition>
  <arm_group>
    <arm_group_label>Control (standard treatment) Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will receive routine cardiac treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SmartHeart Device Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to routine cardiac treatment, participants will wear the SmartHeart device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SmartHeart Device</intervention_name>
    <description>A body-worn device that allows an individual to immediately transmit a 12-lead ECG from anywhere and anytime, using a smartphone application to a physician's office, hospital or monitoring center where designated on-call staff interpret the ECG and make recommendations.</description>
    <arm_group_label>SmartHeart Device Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  â‰¥ 18 years of age.&#xD;
&#xD;
          -  Acute myocardial infarction treated with percutaneous coronary intervention.&#xD;
&#xD;
          -  Patients post AMI and PCI who are planned to be discharged home.&#xD;
&#xD;
          -  Ability to use the device at home.&#xD;
&#xD;
          -  Caring family member who will be able to perform the ECG.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt; 18 years of age.&#xD;
&#xD;
          -  No ability to use the device at home / Unable to comply with the device instructions.&#xD;
&#xD;
          -  No support in home environment.&#xD;
&#xD;
          -  Out of hospital cardiac arrest.&#xD;
&#xD;
          -  Resident of nursing home or acute care facility.&#xD;
&#xD;
          -  Uninterpretable ECG at discharge - left bundle branch block, pacemaker dependence,&#xD;
             implantable cardioverter defibrillator.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joerg Herrmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ryan Veldhuizen</last_name>
    <phone>507-255-0630</phone>
    <email>veldhuizen.ryan@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Faten Sebaali</last_name>
    <phone>507-266-3180</phone>
    <email>seballi.faten@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 7, 2020</study_first_submitted>
  <study_first_submitted_qc>December 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2020</study_first_posted>
  <last_update_submitted>December 7, 2020</last_update_submitted>
  <last_update_submitted_qc>December 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Joerg Herrmann, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

